Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C R Chalmers
Antiangiogenic Activity of the Selective Cyclooxygenase 2 Inhibitor Rofecoxib in Human Colorectal Cancer Liver Metastases
Gut
Gastroenterology
Related publications
Etodolac, a Selective Cyclooxygenase-2 Inhibitor, Inhibits Liver Metastasis of Colorectal Cancer Cells via the Suppression of MMP-9 Activity
International Journal of Molecular Medicine
Medicine
Genetics
Antitumor Activity of the Selective Cyclooxygenase-2 Inhibitor, Celecoxib, on Breast Cancer in Vitro and in Vivo
Cancer Cell International
Cancer Research
Oncology
Genetics
Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
Archives of Internal Medicine
Differential Expression of Cyclooxygenase 2 in Human Colorectal Cancer Reply
Gut
Gastroenterology
Systemic Treatment of Liver Metastases From Colorectal Cancer
Therapeutic Advances in Medical Oncology
Oncology
Colorectal Liver Metastases
Journal of Gastrointestinal Surgery
Surgery
Gastroenterology
Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients
Asian Pacific Journal of Cancer Prevention
Distinct Pattern of Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 mRNA Expression in Human Colorectal Cancer and Liver Metastases
British Journal of Cancer
Cancer Research
Oncology
Interleukin-12 Prevents Colorectal Cancer Liver Metastases in Mice
OncoTargets and Therapy
Oncology
Pharmacology
